News

PTO Litigation Report – July 6, 2017

July 6th, 2017

Listed below are all new filings before the PTAB of petitions for inter partes review (IPR) and covered business methods review (CBM).  Since the last report, no new requests for ex parte reexamination at the USPTO have been posted.  This listing is current as of 8:45 AM on Thursday, July 6, 2017.

New IPR Petitions

Trial Number – IPR2017-01726
Filing Date – 6/30/2017 (Delayed in appearing on E2E)
Patent # – 8,591,897
Title – ANTI-ERBB2 ANTIBODY ADJUVANT THERAPY
Patent Owner –  GENENTECH, INC.
Petitioner – Pfizer, Inc.
Tech Center – 1600

Trial Number – IPR2017-01727
Filing Date – 6/30/2017 (Delayed in appearing on E2E)
Patent # – 8,591,897
Title – ANTI-ERBB2 ANTIBODY ADJUVANT THERAPY
Patent Owner –  GENENTECH, INC.
Petitioner – Pfizer, Inc.
Tech Center – 1600

New CBM Review Petitions

There have been no new petitions for CBM review since the last report.

Newly-Posted Reexam Requests

There have been no new reexam requests posted since the last report.